{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T13:01:45Z","timestamp":1772283705429,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900305"],"award-info":[{"award-number":["81900305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Clinical Research Center for Interventional Medicine","award":["No. 19MC1910300"],"award-info":[{"award-number":["No. 19MC1910300"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["No.shslczdzk01701"],"award-info":[{"award-number":["No.shslczdzk01701"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Early risk stratification of patients with ischemic cardiomyopathy (ICM) and non-ischemic dilated cardiomyopathy (NIDCM) may be beneficial for therapies.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively enrolled all patients admitted for acute heart failure (HF) between January 2019 and December 2021 in Zhongshan Hospital Fudan University, dividing them according to etiology (ICM or NIDCM). Cardiac troponin T (TNT) concentration was compared between two groups. Risk factors for positive TNT and in-hospital all-cause mortality were investigated with regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1525 HF patients were enrolled, including 571 ICM and 954 NIDCM. The TNT positive patients were not different between the two groups (41.3% in ICM group vs. 37.8% in NIDCM group, P\u2009=\u20090.215). However, the TNT value in ICM group were significantly higher than that in NIDCM group (0.025 (0.015\u20130.053) vs. 0.020 (0.014\u20130.041), P\u2009=\u20090.001). NT-proBNP was independently associated with TNT in both ICM and NIDCM group. Although the in-hospital all-cause mortality did not show much difference between the two groups (1.1% vs. 1.9%, P\u2009=\u20090.204), the NIDCM diagnosis was associated with reduced risk of mortality after multiple adjustments (OR 0.169, 95% CI 0.040\u20130.718, P\u2009=\u20090.016). Other independent risk factors included the level of NT-proBNP (OR 8.260, 95% CI 3.168\u201321.533, P\u2009&lt;\u20090.001), TNT (OR 8.118, 95% CI 3.205\u201320.562, P\u2009&lt;\u20090.001), and anemia (OR 0.954, 95% CI 0.931\u20130.978, P\u2009&lt;\u20090.001). The predictive value of TNT and NT-proBNP for all-cause mortality was similar. However, the best cutoff values of TNT for mortality were different between ICM and NIDCM groups, which were 0.113\u00a0ng\/mL and 0.048\u00a0ng\/mL, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The TNT level was higher in ICM patient than that in NIDCM patients. TNT was an independent risk factor for in-hospital all-cause mortality for both ICM and NIDCM patients, although the best cutoff value was higher in ICM patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01169-5","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T09:02:42Z","timestamp":1688374962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy"],"prefix":"10.1186","volume":"28","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"1169_CR1","first-page":"e876","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e876\u201394.","journal-title":"Circulation"},{"key":"1169_CR2","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats A. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272\u201387.","journal-title":"Cardiovasc Res"},{"key":"1169_CR3","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"1169_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","volume":"39","author":"GM Felker","year":"2002","unstructured":"Felker GM, Shaw LK, O\u2019Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39:210\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1169_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/biology11020341","volume":"11","author":"A Tyminska","year":"2022","unstructured":"Tyminska A, Ozieranski K, Balsam P, Maciejewski C, Wancerz A, Brociek E, et al. Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction-clinical characteristics and prognosis depending on heart failure etiology (Data from European Society of Cardiology Heart Failure Registries). Biology. 2022;11:341.","journal-title":"Biology"},{"key":"1169_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/jamacardio.2018.4729","volume":"4","author":"R Corbalan","year":"2019","unstructured":"Corbalan R, Bassand JP, Illingworth L, Ambrosio G, Camm AJ, Fitzmaurice DA, et al. Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation: a report from the GARFIELD-AF registry. JAMA Cardiol. 2019;4:526\u201348.","journal-title":"JAMA Cardiol"},{"key":"1169_CR7","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","volume":"358","author":"WF Peacock","year":"2008","unstructured":"Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117\u201326.","journal-title":"N Engl J Med"},{"key":"1169_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/ejhf.2256","volume":"23","author":"M Packer","year":"2021","unstructured":"Packer M, Januzzi JL, Ferreira JP, Anker SD, Butler J, Filippatos G, et al. Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-reduced trial. Eur J Heart Fail. 2021;23:1529\u201338.","journal-title":"Eur J Heart Fail"},{"key":"1169_CR9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jacc.2012.12.044","volume":"61","author":"DJ van Veldhuisen","year":"2013","unstructured":"van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013;61:1498\u2013506.","journal-title":"J Am Coll Cardiol"},{"key":"1169_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7326\/M16-1468","volume":"166","author":"CN McQuade","year":"2017","unstructured":"McQuade CN, Mizus M, Wald JW, Goldberg L, Jessup M, Umscheid CA. Brain-type natriuretic peptide and amino-terminal pro-brain-type natriuretic peptide discharge thresholds for acute decompensated heart failure: a systematic review. Ann Intern Med. 2017;166:180\u201390.","journal-title":"Ann Intern Med"},{"key":"1169_CR11","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","volume":"50","author":"LB Daniels","year":"2007","unstructured":"Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357\u201368.","journal-title":"J Am Coll Cardiol"},{"key":"1169_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamacardio.2016.4726","volume":"2","author":"A Pandey","year":"2017","unstructured":"Pandey A, Golwala H, Sheng S, DeVore AD, Hernandez AF, Bhatt DL, et al. Factors associated with and prognostic implications of cardiac troponin elevation in decompensated heart failure with preserved ejection fraction: findings From the American Heart Association Get with the guidelines-heart failure program. JAMA Cardiol. 2017;2:136\u201345.","journal-title":"JAMA Cardiol"},{"key":"1169_CR13","first-page":"e240","volume":"128","author":"M Writing Committee","year":"2013","unstructured":"Writing Committee M, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240-327.","journal-title":"Circulation"},{"key":"1169_CR14","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/eurheartj\/ehs191","volume":"33","author":"JL Januzzi Jr","year":"2012","unstructured":"Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012;33:2265\u201371.","journal-title":"Eur Heart J"},{"key":"1169_CR15","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1016\/j.jacc.2018.04.029","volume":"71","author":"BR Weil","year":"2018","unstructured":"Weil BR, Suzuki G, Young RF, Iyer V, Canty JM Jr. Troponin release and reversible left ventricular dysfunction after transient pressure overload. J Am Coll Cardiol. 2018;71:2906\u201316.","journal-title":"J Am Coll Cardiol"},{"key":"1169_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2018.10.079","volume":"277","author":"A Aimo","year":"2019","unstructured":"Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, et al. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol. 2019;277:166\u201372.","journal-title":"Int J Cardiol"},{"key":"1169_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/clc.20075","volume":"30","author":"WL Miller","year":"2007","unstructured":"Miller WL, Hartman KA, Burritt MF, Burnett JC Jr, Jaffe AS. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol. 2007;30:245\u201350.","journal-title":"Clin Cardiol"},{"key":"1169_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00392-011-0285-4","volume":"100","author":"L Frankenstein","year":"2011","unstructured":"Frankenstein L, Remppis A, Giannitis E, Frankenstein J, Hess G, Zdunek D, et al. Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy. Clin Res Cardiol. 2011;100:633\u201340.","journal-title":"Clin Res Cardiol"},{"key":"1169_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacep.2021.06.020","volume":"8","author":"CR Narins","year":"2022","unstructured":"Narins CR, Aktas MK, Chen AY, McNitt S, Ling FS, Younis A, et al. Arrhythmic and mortality outcomes among ischemic versus nonischemic cardiomyopathy patients receiving primary ICD therapy. JACC Clin Electrophysiol. 2022;8:1\u201311.","journal-title":"JACC Clin Electrophysiol"},{"key":"1169_CR20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","volume":"129","author":"B Dinov","year":"2014","unstructured":"Dinov B, Fiedler L, Schonbauer R, Bollmann A, Rolf S, Piorkowski C, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation. 2014;129:728\u201336.","journal-title":"Circulation"},{"key":"1169_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/1871525717666190717160615","volume":"17","author":"TO Mene-Afejuku","year":"2019","unstructured":"Mene-Afejuku TO, Dumancas C, Akinlonu A, Ola O, Cativo EH, Veranyan S, et al. Prognostic utility of troponin I and N terminal-ProBNP among patients with heart failure due to non-ischemic cardiomyopathy and important correlations. Cardiovasc Hematol Agents Med Chem. 2019;17:94\u2013103.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"1169_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1253\/circj.CJ-10-0837","volume":"75","author":"C Kawahara","year":"2011","unstructured":"Kawahara C, Tsutamoto T, Nishiyama K, Yamaji M, Sakai H, Fujii M, et al. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J. 2011;75:656\u201361.","journal-title":"Circ J"},{"key":"1169_CR23","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","volume":"116","author":"R Latini","year":"2007","unstructured":"Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242\u20139.","journal-title":"Circulation"},{"key":"1169_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1071-9164(03)00594-3","volume":"10","author":"CH Del Carlo","year":"2004","unstructured":"Del Carlo CH, Pereira-Barretto AC, Cassaro-Strunz C, Latorre Mdo R, Ramires JA. Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure. J Card Fail. 2004;10:43\u20138.","journal-title":"J Card Fail"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01169-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01169-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01169-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T09:05:18Z","timestamp":1688375118000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01169-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01169-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Zhongshan Hospital, Fudan University. Informed consent was obtained from all the patients. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and the Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}